Akoya Biosciences, Inc. — Form D
Akoya Biosciences, Inc. of Menlo Park, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-14. The offering totals $9.0M, of which $9.0M was reported sold. Industry: Other.
Offering
- Filed: 2017-07-14
- Form: D
- Accession: 0001446933-17-000008
- Industry: Other
- Exemptions: 06b
- Total offering: $9.0M
- Amount sold: $9.0M
- Investors: 6
- Date of first sale: 2017-07-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-290813
Issuer
- Name: Akoya Biosciences, Inc.
- CIK: 0001711933
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1505 O'Brien Drive, Suite A-1, Menlo Park, CA, 94025
- Phone: 650-281-0888
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Rob Hart | Executive Officer | San Francisco, CA |
| Garry Nolan | Director | Menlo Park, CA |
| Thomas Raffin | Director | Menlo Park, CA |
| Matthew Winkler | Director | Menlo Park, CA |
| Brian McKelligon | Director | Menlo Park, CA |
| Brian McKelligon | Executive Officer | Menlo Park, CA |
| Robert Shepler | Director | Menlo Park, CA |
Other filings by this issuer (1)
More